e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Baudax Bio Inc/
Recent news which mentions Baudax Bio Inc/
Lab Notes: Janssen Biotech signs multimillion-dollar cell therapy collaboration and licensing deal
May 05, 2023
Tickers
INNO
Tags
Health Care
Tmunity Therapeutics Inc/
Stan Haas
From
Business Journals
Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
March 31, 2023
Tickers
INNO
Tags
Ocugen Inc/
Insurance
Incyte Corp/
From
Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
December 09, 2022
Tickers
INNO
Tags
Incyte Corp/
Context Therapeutics
Health Care
From
Business Journals
Baudax Bio stock price plummets after firm announces $6.2M public offering
August 30, 2022
Tags
Health Care
Biotech
Baudax Bio Inc/
From
Business Journals
Lab Notes: Tela Bio secures $50M loan deal; Senzo's home Covid-19 test achieves 100% accuracy
June 03, 2022
Tickers
INNO
Tags
OptiNose Inc/
Antony Koblish
Health Care
From
Business Journals
Lab Notes: Spirovant opens new HQ; XyloCor advances gene therapy for heart ailment
May 20, 2022
Tickers
INNO
Tags
Baudax Bio Inc/
Tanja de Gruijl
Teleflex Inc/
From
Business Journals
Lab Notes: Optinose advances sinusitis drug-device combo; WuXi launches new technology
March 11, 2022
Tickers
INNO
Tags
Pharmaceuticals
Ryan Cawood
Insurance
From
Business Journals
Lab Notes: NRx seeks patent for Covid-19 therapy; Baudax Bio raises $4.2M
January 07, 2022
Tickers
INNO
Tags
Health Care
The Wistar Institute
Annovis Bio Inc/
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.